- 专利标题： USE OF MELANOCORTIN-4 RECEPTOR AGONIST IN PREVENTING OR TREATING RARE GENETIC OBESITY DISEASE
-
申请号： EP23753110.8申请日： 2023-02-07
-
公开(公告)号： EP4461297A1公开(公告)日： 2024-11-13
- 发明人: PARK, Hee Dong , HWANG, Hye Kyeong , YEO, Su Jin
- 申请人： LG Chem, Ltd.
- 申请人地址： KR Yeongdeungpo-gu Seoul 07336 128 Yeoui-daero
- 代理机构： Hoffmann Eitle
- 优先权： KR20220016377 20220208
- 国际公布： WO2023153762 20230817
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61P3/04 ; A61K9/00
摘要：
The preset invention relates to a use of a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof for preventing or treating rare genetic obesity diseases associated with a damaged melanocortin-4 receptor (MC4R) pathway, particularly rare genetic obesity diseases associated with proopiomelanocortin (POMC) deficiency.
信息查询
IPC分类:
